There is 1 paper on CG5399 in aging research: none in people yet, 1 in cells.
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
Cells: a single group. Worms or flies, mice and humans: nothing yet.
- 1 lab in 1 country
- Funders: Howard Hughes Medical Institute and 3 more
- Cells1
Effects
2Rapamycin resistance
upin fly cells1
1 study
Rapamycin resistance
upin fly cells1
CG5399 increases rapamycin resistance in fly cells (CRISPR activation under rapamycin).
“The screens identified three genes as novel rapamycin resistance genes”
CellsCRISPR activation under rapamycin
Pooled genome-wide CRISPR activation screening for rapamycin resistance genes in Drosophila cells
eLife
RTK-Akt-mTOR signaling pathway
upin fly cells1
1 study
RTK-Akt-mTOR signaling pathway
upin fly cells1
CG5399 activates RTK-Akt-mTOR signaling pathway in fly cells (shown by overexpression).
“CG5399 overexpression activates the RTK-Akt-mTOR signaling pathway”
Cellsshown by overexpression
Pooled genome-wide CRISPR activation screening for rapamycin resistance genes in Drosophila cells
eLife